BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15531381)

  • 1. Effects of grapefruit juice on the multidrug transporter P-glycoprotein in the human proximal tubular cell line HK-2.
    Romiti N; Tramonti G; Donati A; Chieli E
    Life Sci; 2004 Dec; 76(3):293-302. PubMed ID: 15531381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of different chemicals on MDR-1 P-glycoprotein expression and activity in the HK-2 proximal tubular cell line.
    Romiti N; Tramonti G; Chieli E
    Toxicol Appl Pharmacol; 2002 Sep; 183(2):83-91. PubMed ID: 12387747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albumin influences expression and function of the membrane transporter P-glycoprotein in HK-2 human proximal tubular cells.
    Tramonti G; Romiti N; Chieli E
    J Nephrol; 2009; 22(2):263-72. PubMed ID: 19384845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esterase inhibition by grapefruit juice flavonoids leading to a new drug interaction.
    Li P; Callery PS; Gan LS; Balani SK
    Drug Metab Dispos; 2007 Jul; 35(7):1203-8. PubMed ID: 17452418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P-Glycoprotein inhibitory activity of lipophilic constituents of Echinacea pallida roots in a human proximal tubular cell line.
    Romiti N; Pellati F; Nieri P; Benvenuti S; Adinolfi B; Chieli E
    Planta Med; 2008 Feb; 74(3):264-6. PubMed ID: 18425719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-treatment with grapefruit juice inhibits while chronic administration activates intestinal P-glycoprotein-mediated drug efflux.
    Panchagnula R; Bansal T; Varma MV; Kaul CL
    Pharmazie; 2005 Dec; 60(12):922-7. PubMed ID: 16398269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species difference in the effect of grapefruit juice on intestinal absorption of talinolol between human and rat.
    Shirasaka Y; Kuraoka E; Spahn-Langguth H; Nakanishi T; Langguth P; Tamai I
    J Pharmacol Exp Ther; 2010 Jan; 332(1):181-9. PubMed ID: 19779132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of P-glycoprotein and multidrug resistance proteins in rat kidney and intestinal cell lines.
    van de Water FM; Boleij JM; Peters JG; Russel FG; Masereeuw R
    Eur J Pharm Sci; 2007 Jan; 30(1):36-44. PubMed ID: 17088052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in caco-2 cells.
    Takanaga H; Ohnishi A; Matsuo H; Sawada Y
    Biol Pharm Bull; 1998 Oct; 21(10):1062-6. PubMed ID: 9821810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schisandrol A from Schisandra chinensis reverses P-glycoprotein-mediated multidrug resistance by affecting Pgp-substrate complexes.
    Fong WF; Wan CK; Zhu GY; Chattopadhyay A; Dey S; Zhao Z; Shen XL
    Planta Med; 2007 Mar; 73(3):212-20. PubMed ID: 17318783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells.
    Wan CK; Zhu GY; Shen XL; Chattopadhyay A; Dey S; Fong WF
    Biochem Pharmacol; 2006 Sep; 72(7):824-37. PubMed ID: 16889754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro modulation of ABCB1/P-glycoprotein expression by polyphenols from Mangifera indica.
    Chieli E; Romiti N; Rodeiro I; Garrido G
    Chem Biol Interact; 2010 Aug; 186(3):287-94. PubMed ID: 20513373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of P-glycoprotein activity and reversal of cancer multidrug resistance by Momordica charantia extract.
    Limtrakul P; Khantamat O; Pintha K
    Cancer Chemother Pharmacol; 2004 Dec; 54(6):525-30. PubMed ID: 15248030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-glycoprotein in HK-2 proximal tubule cell line.
    Tramonti G; Romiti N; Norpoth M; Chieli E
    Ren Fail; 2001; 23(3-4):331-7. PubMed ID: 11499549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal drug transporter expression and the impact of grapefruit juice in humans.
    Glaeser H; Bailey DG; Dresser GK; Gregor JC; Schwarz UI; McGrath JS; Jolicoeur E; Lee W; Leake BF; Tirona RG; Kim RB
    Clin Pharmacol Ther; 2007 Mar; 81(3):362-70. PubMed ID: 17215845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of grapefruit juice, naringin, naringenin, and bergamottin on the intestinal carrier-mediated transport of talinolol in rats.
    de Castro WV; Mertens-Talcott S; Derendorf H; Butterweck V
    J Agric Food Chem; 2008 Jun; 56(12):4840-5. PubMed ID: 18494494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of grapefruit juice on digoxin pharmacokinetics in humans.
    Becquemont L; Verstuyft C; Kerb R; Brinkmann U; Lebot M; Jaillon P; Funck-Brentano C
    Clin Pharmacol Ther; 2001 Oct; 70(4):311-6. PubMed ID: 11673746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of induction of tubular epithelial-myofibroblast transition by monocyte chemoattractant protein-1 and mechanism thereof: an in vitro experiment].
    Li HL; Zheng FL; Zhao B
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):400-5. PubMed ID: 18581895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response relationship for the pharmacokinetic interaction of grapefruit juice with dextromethorphan investigated by human urinary metabolite profiles.
    Strauch K; Lutz U; Bittner N; Lutz WK
    Food Chem Toxicol; 2009 Aug; 47(8):1928-35. PubMed ID: 19445995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of cytochrome P450 3A inhibitors with P-glycoprotein.
    Yasuda K; Lan LB; Sanglard D; Furuya K; Schuetz JD; Schuetz EG
    J Pharmacol Exp Ther; 2002 Oct; 303(1):323-32. PubMed ID: 12235267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.